β2-glycoprotein I deficiency:
- 1 October 2000
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 152 (2) , 337-346
- https://doi.org/10.1016/s0021-9150(99)00496-7
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 33 references indexed in Scilit:
- Correlation between β2-glycoprotein I valine/leucine247 polymorphism and anti-β2-glycoprotein I antibodies in patients with primary antiphospholipid syndromeRheumatology, 1999
- Identification of Structural Mutations in the Fifth Domain of Apolipoprotein H ( 2-Glycoprotein I) Which Affect Phospholipid BindingHuman Molecular Genetics, 1997
- Anticardiolipin antibodies and β2-glycoprotein ILupus, 1996
- Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.The Journal of Experimental Medicine, 1994
- Anticardiolipin cofactor(s) and differential diagnosis of autoimmune diseaseThe Lancet, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- Prothrombinase activity of human platelets is inhibited by β2-glycoprotein-IBiochimica et Biophysica Acta (BBA) - General Subjects, 1986
- Characterization of plasma lipids and lipoproteins in patients with β2-glycoprotein I (Apolipoprotein H) deficiencyAtherosclerosis, 1985
- Activation of human post heparin lipoprotein lipase by apolipoprotein H (β2-glycoprotein I)Biochemical and Biophysical Research Communications, 1980
- The binding of β2‐glycoprotein‐I to human serum lipoproteinsFEBS Letters, 1979